This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations in Melanoma Treatment by Willy Hugo
Introduction
Willy Hugo is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of oncology, particularly in the treatment of metastatic melanomas. His innovative approach focuses on enhancing the effectiveness of anti-PD-1 therapy, which is crucial for patients suffering from this aggressive form of skin cancer.
Latest Patents
Willy Hugo holds a patent for a method titled "Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas." This patent outlines methods for predicting or detecting sensitivity to therapeutic effects of anti-PD-1 therapy in patients with melanoma. The invention involves analyzing tumor samples through various advanced techniques, including whole transcriptome sequencing and mass spectrometry. The goal is to identify patients who are candidates for anti-PD-1 therapy, thereby improving treatment outcomes.
Career Highlights
Willy Hugo is affiliated with the University of California, where he conducts research and develops innovative solutions for cancer treatment. His work has garnered attention for its potential to transform the way melanoma is treated, particularly for patients who do not respond to conventional therapies.
Collaborations
Willy collaborates with notable colleagues such as Jesse Zaretsky and Antoni Ribas. Their combined expertise enhances the research efforts aimed at improving therapeutic strategies for melanoma patients.
Conclusion
Willy Hugo's contributions to melanoma treatment through his innovative patent demonstrate his commitment to advancing cancer therapy. His work not only provides hope for patients but also sets a precedent for future research in the field.